ID   CNTN3_HUMAN             Reviewed;        1028 AA.
AC   Q9P232; B9EK50; Q9H039;
DT   23-NOV-2004, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 3.
DT   28-JUN-2023, entry version 171.
DE   RecName: Full=Contactin-3;
DE   AltName: Full=Brain-derived immunoglobulin superfamily protein 1;
DE            Short=BIG-1;
DE   AltName: Full=Plasmacytoma-associated neuronal glycoprotein;
DE   Flags: Precursor;
GN   Name=CNTN3; Synonyms=KIAA1496, PANG;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT SER-708.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 109-1028.
RC   TISSUE=Brain;
RX   PubMed=10819331; DOI=10.1093/dnares/7.2.143;
RA   Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVII. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 7:143-150(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 984-1028.
RC   TISSUE=Brain;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=11013081; DOI=10.1006/geno.2000.6310;
RA   Kamei Y., Takeda Y., Teramoto K., Tsutsumi O., Taketani Y., Watanabe K.;
RT   "Human NB-2 of the contactin subgroup molecules: chromosomal localization
RT   of the gene (CNTN5) and distinct expression pattern from other subgroup
RT   members.";
RL   Genomics 69:113-119(2000).
RN   [6]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-489; ASN-860 AND ASN-931.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J.,
RA   Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [7]
RP   INTERACTION WITH PTPRG.
RX   PubMed=20133774; DOI=10.1073/pnas.0911235107;
RA   Bouyain S., Watkins D.J.;
RT   "The protein tyrosine phosphatases PTPRZ and PTPRG bind to distinct members
RT   of the contactin family of neural recognition molecules.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:2443-2448(2010).
RN   [8]
RP   STRUCTURE BY NMR OF 893-996.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the fourth FN3 domain of KIAA1496 protein.";
RL   Submitted (NOV-2004) to the PDB data bank.
CC   -!- FUNCTION: Contactins mediate cell surface interactions during nervous
CC       system development. Has some neurite outgrowth-promoting activity (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with PTPRG. {ECO:0000269|PubMed:20133774}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Lipid-anchor, GPI-
CC       anchor {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: In brain, it is expressed in frontal lobe,
CC       occipital lobe, cerebellum and amygdala. {ECO:0000269|PubMed:11013081}.
CC   -!- SIMILARITY: Belongs to the immunoglobulin superfamily. Contactin
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC016950; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC024222; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC128653; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC128656; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC150608; AAI50609.1; -; mRNA.
DR   EMBL; AB040929; BAA96020.1; -; mRNA.
DR   EMBL; AL512746; CAC21671.1; -; mRNA.
DR   CCDS; CCDS33790.1; -.
DR   RefSeq; NP_065923.1; NM_020872.2.
DR   RefSeq; XP_005264814.1; XM_005264757.3.
DR   RefSeq; XP_016861996.1; XM_017006507.1.
DR   PDB; 1WJ3; NMR; -; A=893-996.
DR   PDBsum; 1WJ3; -.
DR   AlphaFoldDB; Q9P232; -.
DR   SMR; Q9P232; -.
DR   IntAct; Q9P232; 4.
DR   MINT; Q9P232; -.
DR   STRING; 9606.ENSP00000263665; -.
DR   GlyConnect; 1931; 10 N-Linked glycans (9 sites).
DR   GlyCosmos; Q9P232; 13 sites, 10 glycans.
DR   GlyGen; Q9P232; 13 sites, 10 N-linked glycans (9 sites).
DR   iPTMnet; Q9P232; -.
DR   PhosphoSitePlus; Q9P232; -.
DR   BioMuta; CNTN3; -.
DR   DMDM; 296439395; -.
DR   MassIVE; Q9P232; -.
DR   PaxDb; Q9P232; -.
DR   PeptideAtlas; Q9P232; -.
DR   ProteomicsDB; 83720; -.
DR   Antibodypedia; 1216; 173 antibodies from 24 providers.
DR   DNASU; 5067; -.
DR   Ensembl; ENST00000263665.7; ENSP00000263665.6; ENSG00000113805.9.
DR   GeneID; 5067; -.
DR   KEGG; hsa:5067; -.
DR   MANE-Select; ENST00000263665.7; ENSP00000263665.6; NM_020872.3; NP_065923.1.
DR   UCSC; uc003dpm.2; human.
DR   AGR; HGNC:2173; -.
DR   CTD; 5067; -.
DR   DisGeNET; 5067; -.
DR   GeneCards; CNTN3; -.
DR   HGNC; HGNC:2173; CNTN3.
DR   HPA; ENSG00000113805; Tissue enhanced (brain).
DR   MIM; 601325; gene.
DR   neXtProt; NX_Q9P232; -.
DR   OpenTargets; ENSG00000113805; -.
DR   PharmGKB; PA26687; -.
DR   VEuPathDB; HostDB:ENSG00000113805; -.
DR   eggNOG; KOG3513; Eukaryota.
DR   GeneTree; ENSGT00940000160282; -.
DR   HOGENOM; CLU_005756_0_0_1; -.
DR   InParanoid; Q9P232; -.
DR   OMA; HKLMGAR; -.
DR   OrthoDB; 3073820at2759; -.
DR   PhylomeDB; Q9P232; -.
DR   TreeFam; TF351103; -.
DR   PathwayCommons; Q9P232; -.
DR   Reactome; R-HSA-163125; Post-translational modification: synthesis of GPI-anchored proteins.
DR   SignaLink; Q9P232; -.
DR   BioGRID-ORCS; 5067; 6 hits in 1144 CRISPR screens.
DR   ChiTaRS; CNTN3; human.
DR   EvolutionaryTrace; Q9P232; -.
DR   GeneWiki; CNTN3; -.
DR   GenomeRNAi; 5067; -.
DR   Pharos; Q9P232; Tbio.
DR   PRO; PR:Q9P232; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q9P232; protein.
DR   Bgee; ENSG00000113805; Expressed in Brodmann (1909) area 23 and 147 other tissues.
DR   Genevisible; Q9P232; HS.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   CDD; cd00063; FN3; 4.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 10.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   PANTHER; PTHR44170:SF18; CONTACTIN 3B-RELATED; 1.
DR   PANTHER; PTHR44170; PROTEIN SIDEKICK; 1.
DR   Pfam; PF00041; fn3; 4.
DR   Pfam; PF07679; I-set; 2.
DR   Pfam; PF13927; Ig_3; 4.
DR   SMART; SM00060; FN3; 4.
DR   SMART; SM00409; IG; 6.
DR   SMART; SM00408; IGc2; 6.
DR   SUPFAM; SSF49265; Fibronectin type III; 2.
DR   SUPFAM; SSF48726; Immunoglobulin; 6.
DR   PROSITE; PS50853; FN3; 4.
DR   PROSITE; PS50835; IG_LIKE; 6.
PE   1: Evidence at protein level;
KW   3D-structure; Cell adhesion; Cell membrane; Disulfide bond; Glycoprotein;
KW   GPI-anchor; Immunoglobulin domain; Lipoprotein; Membrane;
KW   Reference proteome; Repeat; Signal.
FT   SIGNAL          1..19
FT                   /evidence="ECO:0000255"
FT   CHAIN           20..1002
FT                   /note="Contactin-3"
FT                   /id="PRO_0000014705"
FT   PROPEP          1003..1028
FT                   /note="Removed in mature form"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000014706"
FT   DOMAIN          26..117
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          122..208
FT                   /note="Ig-like C2-type 2"
FT   DOMAIN          227..313
FT                   /note="Ig-like C2-type 3"
FT   DOMAIN          318..402
FT                   /note="Ig-like C2-type 4"
FT   DOMAIN          408..497
FT                   /note="Ig-like C2-type 5"
FT   DOMAIN          499..593
FT                   /note="Ig-like C2-type 6"
FT   DOMAIN          600..698
FT                   /note="Fibronectin type-III 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          703..800
FT                   /note="Fibronectin type-III 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          805..901
FT                   /note="Fibronectin type-III 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          902..998
FT                   /note="Fibronectin type-III 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   REGION          684..713
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   LIPID           1002
FT                   /note="GPI-anchor amidated serine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        65
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        193
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        375
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        468
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        489
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16335952"
FT   CARBOHYD        765
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        860
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16335952"
FT   CARBOHYD        895
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        913
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        931
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16335952"
FT   CARBOHYD        956
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        50..100
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        144..196
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        249..297
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        339..386
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        431..479
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        521..577
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VARIANT         630
FT                   /note="S -> N (in dbSNP:rs626578)"
FT                   /id="VAR_019906"
FT   VARIANT         708
FT                   /note="N -> S (in dbSNP:rs626578)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_056042"
FT   STRAND          918..922
FT                   /evidence="ECO:0007829|PDB:1WJ3"
FT   STRAND          930..932
FT                   /evidence="ECO:0007829|PDB:1WJ3"
FT   STRAND          935..946
FT                   /evidence="ECO:0007829|PDB:1WJ3"
FT   STRAND          951..963
FT                   /evidence="ECO:0007829|PDB:1WJ3"
FT   STRAND          970..980
FT                   /evidence="ECO:0007829|PDB:1WJ3"
FT   STRAND          989..991
FT                   /evidence="ECO:0007829|PDB:1WJ3"
SQ   SEQUENCE   1028 AA;  112883 MW;  575945CD75D21844 CRC64;
     MMFPWKQLIL LSFIGCLGGE LLLQGPVFIK EPSNSIFPVG SEDKKITLHC EARGNPSPHY
     RWQLNGSDID MSMEHRYKLN GGNLVVINPN RNWDTGTYQC FATNSLGTIV SREAKLQFAY
     LENFKTKMRS TVSVREGQGV VLLCGPPPHS GELSYAWIFN EYPSFVEEDS RRFVSQETGH
     LYISKVEPSD VGNYTCVVTS MVTNARVLGS PTPLVLRSDG VMGEYEPKIE VQFPETLPAA
     KGSTVKLECF ALGNPIPQIN WRRSDGLPFS SKIKLRKFSG VLEIPNFQQE DAGSYECIAE
     NSRGKNVARG RLTYYAKPHW VQLIKDVEIA VEDSLYWECR ASGKPKPSYR WLKNGAALVL
     EERTQIENGA LTISNLSVTD SGMFQCIAEN KHGLVYSSAE LKVVASAPDF SKNPMKKLVQ
     VQVGSLVSLD CKPRASPRAL SSWKKGDVSV QEHERISLLN DGGLKIANVT KADAGTYTCM
     AENQFGKANG TTHLVVTEPT RITLAPSNMD VSVGESVILP CQVQHDPLLD IIFTWYFNGA
     LADFKKDGSH FEKVGGSSSG DLMIRNIQLK HSGKYVCMVQ TGVDSVSSAA DLIVRGSPGP
     PENVKVDEIT DTTAQLSWKE GKDNHSPVIS YSIQARTPFS VGWQTVTTVP EVIDGKTHTA
     TVVELNPWVE YEFRVVASNK IGGGEPSLPS EKVRTEEAVP EVPPSEVNGG GGSRSELVIT
     WDPVPEELQN GEGFGYVVAF RPLGVTTWIQ TVVTSPDTPR YVFRNESIVP YSPYEVKVGV
     YNNKGEGPFS PVTTVFSAEE EPTVAPSQVS ANSLSSSEIE VSWNTIPWKL SNGHLLGYEV
     RYWNGGGKEE SSSKMKVAGN ETSARLRGLK SNLAYYTAVR AYNSAGAGPF SATVNVTTKK
     TPPSQPPGNV VWNATDTKVL LNWEQVKAME NESEVTGYKV FYRTSSQNNV QVLNTNKTSA
     ELVLPIKEDY IIEVKATTDG GDGTSSEQIR IPRITSMDAR GSTSAISNVH PMSSYMPIVL
     FLIVYVLW
//
